Ridgeline Discovery Engine

Ridgeline Discovery is a Basel-based discovery engine established by Versant Ventures to create and launch innovative biotechnology companies. The organization operates as a centralized R&D hub, providing the expertise and laboratory infrastructure necessary to translate breakthrough science into drug discovery programs. Ridgeline focuses on a variety of therapeutic modalities, including small molecules, biologics, and protein degraders, primarily targeting oncology and immunology. Since its inception, the engine has successfully incubated and spun out several high-profile companies such as Monte Rosa Therapeutics and Black Diamond Therapeutics. By integrating deep biological insights with drug hunting capabilities, Ridgeline continues to build a robust portfolio of precision medicine ventures.